Key points are not available for this paper at this time.
The anticancer drug, doxorubicin (DOX), was loaded onto DNA-capped gold nanoparticles (AuNP) designed for specific DOX intercalation. Drug binding was confirmed by monitoring DNA melting temperature, AuNP plasmon resonance maximum, and hydrodynamic radius increase, as a function of DOX/DNA ratio. The capacity for drug release to target DNA was confirmed.
Alexander et al. (2011) studied this question.